Paxman AB

PINK:PXMBF USA Medical Devices
Market Cap
$81.46 Million
Market Cap Rank
#21327 Global
#7653 in USA
Share Price
$3.50
Change (1 day)
+0.00%
52-Week Range
$3.50 - $3.50
All Time High
$7.30
About

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of … Read more

Paxman AB (PXMBF) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.014x

Based on the latest financial reports, Paxman AB (PXMBF) has a cash flow conversion efficiency ratio of -0.014x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.98 Million) by net assets ($427.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Paxman AB - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Paxman AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Paxman AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Paxman AB ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Paxman AB (2017–2024)

The table below shows the annual cash flow conversion efficiency of Paxman AB from 2017 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $163.99 Million $39.10 Million 0.238x +87.04%
2023-12-31 $122.62 Million $15.63 Million 0.127x +442.03%
2022-12-31 $114.20 Million $2.69 Million 0.024x +171.39%
2021-12-31 $125.75 Million $-4.14 Million -0.033x +95.77%
2020-12-31 $10.89 Million $-8.48 Million -0.779x -768.59%
2019-12-31 $28.36 Million $3.31 Million 0.117x +639.81%
2018-12-31 $25.39 Million $400.00K 0.016x +107.24%
2017-12-31 $32.77 Million $-7.13 Million -0.218x --